Login
$ALT
$2.05 -$0.07 (3.3%) Close

$ALT 4/A SEC Filings

Filed On Filing
16 Feb 2022 Form 4/A: Drutz David, Director

Granted 278 Stock Options (option to buy)

26 Aug 2011 Form 4/A: Schaffer Derace L, Director

Bought 0 shares · Bought 0 shares

01 Jun 2010 Form 4/A: Pappajohn John, Director

Bought 54,344 shares ($80.9K) · Bought 45,656 shares ($68.9K)

17 May 2010 Form 4/A: Fusco Joan, SVP, Operations

Granted 10,000 Stock Option (right to buy)

13 Nov 2007 Form 4/A: Healthcare Ventures Vii Lp, 10% owner and 6 others

Bought 125,000 shares ($958K) · Acquired 3,067,243 shares (Other Transaction) · Acquired 0 8% Convertible Note (Other Transaction)

29 Oct 2007 Form 4/A: Gadicke Ansbert, 10% owner

Granted 1,104 Stock Option(Right to Buy)

03 Oct 2007 Form 4/A: Evnin Luke, 10% owner and 6 others

Acquired 3,239,443 shares (Other Transaction) · Acquired 0 8% Convertible Note (Other Transaction) · Granted 1,104 Stock Option (Right to Buy) · 1 more

03 Oct 2007 Form 4/A: Mpm Bioventures Iii Llc, 10% owner and 6 others

Acquired 3,239,443 shares (Other Transaction) · Acquired 0 8% Convertible Note (Other Transaction) · Granted 1,104 Stock Option (Right to Buy) · 1 more

06 Sep 2007 Form 4/A: Wright David P, Director

Acquired 50,541 shares (Other Transaction) · Granted 103,533 Stock Option (right to buy) · Granted 5,313 Unsecured Convertible Note · 3 more

17 Aug 2007 Form 4/A: Wright David P, Director

Acquired 50,542 shares (Other Transaction) · Granted 103,533 Stock Option (right to buy) · Granted 5,313 Unsecured Convertible Note · 1 more

16 Aug 2007 Form 4/A: Kinley Matthew P, Former President & Treasurer

Bought 50,000 shares ($383K)

16 Aug 2007 Form 4/A: Pappajohn John, Director

Bought 60,000 shares ($462K)

10 Aug 2007 Form 4/A: Gadicke Ansbert, 10% owner

Granted 996 Stock Option(Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support